康龙化成:90%员工是研发生产,人才壁垒如何铸就CXO龙头?

药事纵横
Sep 01

康龙化成成立于2004年,由楼柏良博士和楼小强博士这对海归兄弟在北京共同创立。2000年前后,全球大型制药公司为降低高昂的研发成本、加快新药研发速度,CRO这一模式开始兴起并逐渐成为主流。康龙化成正是抓住了这一机遇,从最基础的化学合成服务起步。初期,公司专注于为跨国药企提供化合物设计、化学合成、工艺开发等实验室研究服务。营收情况分析康龙化成近日发布的2025年半年度报告,再次向市场展示了其作为全球...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10